FindTrial
Sign In

The current status of treatment for gastrointestinal stromal tumors in the real word

The current status of treatment for gastrointestinal stromal tumors in the real word

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020473
Enrollment
Unknown
Registered
2018-12-31
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal stromal tumors

Interventions

Case series:Case series

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of gastrointestinal stromal tumors confirmed by pathological and immunohistochemical analyses; 2. Patients who received preoperative or postoperative imatinib treatment.

Exclusion criteria

Exclusion criteria: 1. pregnant or nursing women; 2. patients with severe diseases of other systems or coexistence of any other malignancies

Design outcomes

Primary

MeasureTime frame
Response evaluation of imatinib;Surgical resection rate;Recurrence-free survival;Overall survival;Safety evaluation;—

Countries

China

Contacts

Public ContactBo Zhang

West China Hospital, Sichuan University

zhangbo7310@126.com+86 18980601891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026